Celyad Oncology SA
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$8,448,000 and profit margin reached -8282%. Total operating expenses were $8,490,000.

Profit Margin

Celyad Oncology SA (LSE:0QFK.L): Profit margin
2014 146K -16.45M -11269.18%
2015 3K -29.11M -970466.67%
2016 8.52M -23.60M -276.97%
2017 3.54M -56.39M -1593.08%
2018 3.11M -37.42M -1201.51%
2019 6K -28.63M -477200%
2020 5K -17.20M -344080%
2021 0 -26.51M
2022 0 -40.93M
2023 102K -8.44M -8282.35%

0QFK.L Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
102K005K6K3.11M3.54M8.52M3K146K
Cost of revenue
69K1.44M1.52M0002.22M1.56M1.03M115K
Gross profit
33K-1.44M-1.52M5K6K3.11M1.31M6.95M-1.03M31K
Operating exp.
Research and development
3.88M17.69M19.49M20.07M23.78M24.10M21.42M26.33M21.73M15.86M
Selling and marketing
215K239K434K454K607K676K761K728K891K394K
Total operating expenses
8.49M28.03M29.48M29.07M32.63M35.22M30.50M35.90M28.55M16.73M
Operating income
-8.45M-29.47M-31.00M-30.90M-34.41M-33.21M-29.19M-28.94M-29.58M-16.74M
Other income (expenses), net
-54K-11.85M3.82M13.04M4.21M-4.51M-28.36M5.33M216K-16K
Income before tax
-8.51M-41.33M-27.18M-17.86M-30.2M-37.73M-57.55M-23.61M-29.36M-16.45M
Income tax expense
-191K-397K-677K-657K-1.56M-310K-1.16M-6K-251.99K0
Net income
-8.44M-40.93M-26.51M-17.20M-28.63M-37.42M-56.39M-23.60M-29.11M-16.45M
Earnings per share
Basic EPS
-0.33-1.81-1.7-1.23-2.29-3.36-5.86-2.53-3.43-2.44
Diluted EPS
-0.33-1.81-1.7-1.23-2.29-3.36-5.86-2.53-3.43-2.44
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source